Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy Cover

.blurhash-client-img { display: none !important; }

Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy

Radiology and Oncology

Volume 52 (2018): Issue 4 (December 2018)

By: Martina Vrankar and Mojca Unk

Open Access

|Oct 2018

Authors

Martina Vrankar

mvrankar@onko-i.si

Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Mojca Unk

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2018-0037 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 365 - 369

Submitted on: Feb 5, 2018

|

Accepted on: Mar 12, 2018

|

Published on: Oct 18, 2018

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

symptomatic pseudoprogression,

atypical response,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2018 Martina Vrankar, Mojca Unk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 52 (2018): Issue 4 (December 2018)Next article